IBS - About the company
IBS is a public company based in New York City (United States), founded in 2016. It operates as a Developer of fingerprint drug testing and sweat drug monitoring solutions. IBS has raised an undisclosed amount in funding. The company has 282 active competitors, including 61 funded and 24 that have exited. Its top competitors include companies like Livongo, mySugr and WakeCap.
Company Details
Developer of fingerprint drug testing and sweat drug monitoring solutions. The company provides a system that detects drugs via fingertip sweat. It also offers a wearable patch that detects drug use through sweat over several days. The patch is designed for longer-term monitoring purposes.
- Website
- ibs.inc
- Social
- Email ID
- *****@ibs.inc
- Registered Address
- 142 WEST 57TH ST FL11,NEW YORK,10019,NY
Key Metrics
Founded Year
2016
Location
New York City, United States
Stage
Public
Latest Funding Round
Ranked
19th among 282 active competitors
Annual Revenue
$1M - $10M as on Jun 30, 2026
Employee Count
37 as on Sep 30, 2026
Exit Details
Public
Legal entities associated with IBS
IBS is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
Intelligent Bio Solutions Inc. CIN: 1725430 , United States, Active | $1M - $10M (As on Jun 30, 2026) | - | - |
IBS's IPO details
IBS got listed on Apr 20, 2022.
Click here to take a look at IBS's IPO in detail
Sign up to download IBS's company profile
IBS's funding and investors
IBS has raised funding over 3 rounds. Its first funding round was on Mar 12, 2024.
Here is the list of recent funding rounds of IBS:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Aug 31, 2026 | 6726043 | Post IPO | 7530277 | 5881552 | 9023334 | 5662595 |
Dec 31, 2025 | 3991893 | Post IPO | 7724062 | 3367801 | 2521761 | 6740135 |
Mar 12, 2024 | 6474626 | Post IPO | 6934921 | 7249479 | 8380745 | 1689765 |
Access funding benchmarks and valuations. Sign up today!View details of IBS's funding rounds and investors
IBS's founders and board of directors
Founder? Claim ProfileIBS's employee count trend
IBS has 37 employees as of Sep 26. Here is IBS's employee count trend over the years:
Uncover IBS's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
IBS's Competitors and alternates
Top competitors of IBS include Livongo, mySugr and WakeCap. Here is the list of Top 10 competitors of IBS, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Livongo 2014, San Francisco (United States), Acquired | Provider of smart devices for diabetes management for patients and doctors | $245M | 67/100 | |
2nd | Gamification apps for diabetes management and therapy | $4.8M | 67/100 | ||
3rd | WakeCap 2017, Riyadh (Saudi Arabia), Series B | Provider of sensor-powered project-controls system for workforce visibility and intelligence | $32M | 66/100 | |
4th | Jana Care 2011, Newton (United States), Series C | Provider of mobile-based healthcare diagnostics for diabetes prevention | $35.7M | 64/100 | |
5th |  Kinetic 2014, New York City (United States), Series A | Provider of tech-driven injury reduction programs | $15.8M | 59/100 | |
6th |  DarioHealth 2011, New York City (United States), Public | Platform for chronic conditions management | $6.01M | 59/100 | |
7th |  Aatmunn 2014, Farmington (United States), Series B | Provider of workplace safety and inspection management | $28M | 59/100 | |
8th | Manufacturer of industrial internet of things safety gear and wearables | $6.73M | 58/100 | ||
9th |  One Drop 2015, New York City (United States), Series C | Provider of workforce healthcare solutions | $108M | 56/100 | |
10th | Telcare 2008, Bethesda (United States), Acquired | Cellular technology and social networking to tackle diabetes | $66.7M | 55/100 | |
19th |  IBS 2016, New York City (United States), Public | Developer of fingerprint drug testing and sweat drug monitoring solutions | - | - | 49/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on IBS's competitors? Click here to see the top ones
IBS's Investments and acquisitions
IBS has made no investments or acquisitions yet.
Reports related to IBS
Here is the latest report on IBS's sector:
News related to IBS
Filter this listMedia has covered IBS for a total of 25 events in the last 1 year, 9 of them have been about company updates and 4 about partnerships.
•
•
•
Intelligent Bio Solutions GAAP EPS of -$8.44, revenue of $4.22M (INBS:NASDAQ)Seeking Alpha•Aug 20, 2026•IBS
•
Intelligent Bio Solutions Secures ISO Recertification, Aligning With New FDA QMSRRttnews•Aug 18, 2026•IBS
•
•
•
Intelligent Bio Solutions Inc. Completes Interference Study for Intelligent Fingerprinting Drug Screening SystemStock Screener•Aug 03, 2026•IBS
•
•
Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-YearGlobeNewswire•May 13, 2026•IBS
•
Intelligent Bio Solutions Initiates Validation Study for Rapid Drug ScreeningGlobeNewswire•Apr 20, 2026•IBS
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about IBS
Explore our recently published companies
- TradeFlow Planner - Unfunded company
- AMPIN Energy Transition - India based, 2023 founded, Unfunded company
- ZSU Webdesign - Hungary based, Unfunded company
- Zuka - United Arab Emirates based, Unfunded company
- Zogglar - Brazil based, 2006 founded, Unfunded company
- Zimmerei Menz - Wenzlow based, Unfunded company
